NASDAQ
Biostage, Inc. (BSTG) has a free cash flow growth of -41.11% as of Friday, May 29, 2026. This represents a 11.73% decrease compared to its 12-month average of -36.80%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.